CBD

Cannabidiol (CBD) is one of the two main active compounds in medicinal cannabis preparations legally prescribed in New Zealand. Unlike THC, CBD is not psychoactive, which means it does not produce a “high.” Under the Medicinal Cannabis Scheme, CBD is a prescription medicine, not an over-the-counter supplement.

What CBD Is and What It Is Not

CBD (cannabidiol) is one of more than 100 cannabinoids found in the Cannabis sativa plant. Unlike THC (delta-9-tetrahydrocannabinol), CBD does not produce the “high” associated with cannabis at typical doses. In New Zealand, CBD is classified as a prescription medicine under the Misuse of Drugs Act1975. When isolated and kept below a2% THC threshold it is not a controlled drug, but the Medicinal Cannabis Scheme still requires a prescription from a registered medical practitioner. That means any product calling itself “CBD oil” outside the scheme is either unregulated or illegal.

The most common misconception is that “medicinal cannabis” lets a patient legally smoke raw plant material. Under the scheme, the lawful product is a manufactured pharmaceutical that meets GMP (Good Manufacturing Practice) standards and has been approved by the Ministry of Health. Raw flower is available only as a prescribed, pharmacy-dispensed pharmaceutical, not through a dispensary or a general licence. The scheme does not create a legal right to use unregulated cannabis, and it does not legalise possession of raw plant material outside a prescription.

How the Medicinal Cannabis Scheme Works

The scheme is administered by the Medicinal Cannabis Agency (MCA) within Medsafe, the Medicines and Medical Devices Safety Authority. It was established under the Misuse of Drugs (Medicinal Cannabis) Amendment Act2018, and the first preparations became available from1 April2020. Prescriptions are written by doctors, not pharmacists, and the items are dispensed through licensed pharmacies. There is no “cannabis clinic” or “dispensary” in the recreational sense; raw flower is a prescribed pharmaceutical, not a retail item.

Every medicinal cannabis product must be manufactured to GMP standards and receive Ministry of Health approval. Prescribers use the NZ Formulary as the official prescribing reference; it includes cannabis product monographs and clinical guidance.

What the Research Shows

The supporting data is uneven. The strongest clinical support is for certain childhood epilepsy syndromes. For Dravet and Lennox-Gastaut syndromes, the FDA-approved Epidiolex (a purified CBD) reduced seizure frequency in randomised trials; the NZ Formulary lists Epidyolex as a funded option for these conditions, and the2018 GW Pharmaceuticals trial showed a44% median reduction in drop seizures.

For chronic pain, anxiety, and sleep, the findings are mixed. A2023 systematic review by the International Association for the Study of Pain found that CBD alone has limited data, but THC:CBD combinations show moderate support for neuropathic pain. For anxiety, some small trials show benefit, but the NZ Formulary notes that CBD for anxiety is not currently backed by high-quality studies. For cancer-related symptoms, the research is stronger for nausea and vomiting (THC-based) than for pain; a2021 systematic review found moderate-quality data for pain reduction in advanced cancer, but no effect on nausea or vomiting. The Ministry of Health’s2020 position statement describes the research base for medicinal cannabis as “emerging” and “not yet robust” for most conditions, except for a few specific uses such as refractory epilepsy where the data are stronger.

Conditions With the Strongest Support

• Refractory epilepsy (Dravet and Lennox-Gastaut syndromes): Pharmaceutical CBD (Epidyolex) is a funded option with trial evidence of reduced drop seizures.- Neuropathic pain: THC:CBD combinations show moderate-quality data, though CBD alone has limited support.- Cancer-related pain: Moderate-quality data for pain reduction in advanced cancer, but not for nausea or vomiting.

Conditions With Mixed or Limited Data

• Anxiety: Small trials show possible benefit, but high-quality studies are lacking.- Sleep: Systematic reviews are mostly based on short-term studies or small samples.- General chronic pain: CBD alone lacks robust evidence; combination preparations have stronger, but still modest, support.

How to Access CBD Lawfully

1. Consult a doctor. Any registered medical practitioner can prescribe, not just specialists.2. Obtain a prescription. The doctor assesses your condition against the available evidence and the NZ Formulary guidance.3. Fill the prescription at a licensed pharmacy. The product must be sourced through the Medicinal Cannabis Scheme, meet GMP standards, and carry Ministry of Health approval.4. Do not buy online or over the counter. Any CBD item sold outside this pathway is unregulated or illegal in New Zealand.

What to Consider Before Use

• Driving and operating machinery. CBD can cause drowsiness, fatigue, or lowered blood pressure in some people. Do not drive or use heavy machinery until you know how a dose affects you.- Drug interactions. CBD inhibits certain liver enzymes (particularly CYP450 family), which can alter how your body processes other medicines. Tell your prescriber about every medicine and supplement you take.- Side effects. Common ones include diarrhoea, changes in appetite, and tiredness. Liver function changes have been noted at high doses in some studies.- Pregnancy and breastfeeding. Safety data are absent. The Ministry of Health advises against use during pregnancy or while breastfeeding.- Quality and dose. Prescribed preparations have standardised cannabinoid content and GMP-level quality control. Unregulated products carry unknown potency, contaminants, and legal risk.

Common Questions

Is CBD the same as medicinal cannabis?CBD is one component of medicinal cannabis. Medicinal cannabis may contain CBD only, THC only, or a combination of both, depending on the prescription.

Can I bring CBD into New Zealand from overseas?Not without prior approval. Importing a prescription medicine containing CBD requires a licence or a prescription from a New Zealand-registered practitioner, and the product must comply with the scheme’s requirements.

Does CBD show up on a drug test?Pure CBD should not trigger a standard workplace drug screen for THC, but full-spectrum or broad-spectrum preparations may contain trace THC. If your job requires drug testing, discuss this with your prescriber before starting any cannabinoid medicine.

Will CBD make me feel “high”?At prescribed doses, CBD is non-intoxicating and does not produce the euphoria associated with THC. Some people report feeling calmer or sleepier, which is not the same as impairment.